BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35943661)

  • 1. The Gut Microbiome and Colonic Motility Disorders: A Practical Framework for the Gastroenterologist.
    Ma W; Drew DA; Staller K
    Curr Gastroenterol Rep; 2022 Oct; 24(10):115-126. PubMed ID: 35943661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Singh P; Lembo A
    Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual reinforcement of pathophysiological host-microbe interactions in intestinal stasis models.
    Touw K; Ringus DL; Hubert N; Wang Y; Leone VA; Nadimpalli A; Theriault BR; Huang YE; Tune JD; Herring PB; Farrugia G; Kashyap PC; Antonopoulos DA; Chang EB
    Physiol Rep; 2017 Mar; 5(6):. PubMed ID: 28320888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
    Kurokawa S; Kishimoto T; Mizuno S; Masaoka T; Naganuma M; Liang KC; Kitazawa M; Nakashima M; Shindo C; Suda W; Hattori M; Kanai T; Mimura M
    J Affect Disord; 2018 Aug; 235():506-512. PubMed ID: 29684865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritable bowel syndrome and gut microbiota.
    Canakis A; Haroon M; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):28-35. PubMed ID: 31789724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and irritable bowel syndrome.
    Zhao Y; Zou DW
    J Dig Dis; 2023 May; 24(5):312-320. PubMed ID: 37458142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
    Mamieva Z; Poluektova E; Svistushkin V; Sobolev V; Shifrin O; Guarner F; Ivashkin V
    World J Gastroenterol; 2022 Mar; 28(12):1204-1219. PubMed ID: 35431513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?
    Shaukat A; Brenner DM
    Am J Gastroenterol; 2019 Jul; 114(7):1032-1033. PubMed ID: 31082878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation for managing irritable bowel syndrome.
    El-Salhy M; Mazzawi T
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transfer for bowel disorders: efficacy or hype?
    Schmulson M; Bashashati M
    Curr Opin Pharmacol; 2018 Dec; 43():72-80. PubMed ID: 30218939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal microbiota transplantation for gastrointestinal disorders.
    Malikowski T; Khanna S; Pardi DS
    Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders.
    Singh R; Zogg H; Ghoshal UC; Ro S
    Front Pharmacol; 2022; 13():808195. PubMed ID: 35145413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
    Pearson JS; Whorwell PJ
    Curr Opin Gastroenterol; 2017 Jan; 33(1):21-25. PubMed ID: 28134688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota as potential orchestrators of irritable bowel syndrome.
    Bennet SM; Ohman L; Simren M
    Gut Liver; 2015 May; 9(3):318-31. PubMed ID: 25918261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
    Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between the Gut Microbiome and Colonic Motility in Chronic Constipation: Potential Mechanisms and Microbiota Modulation.
    Pan R; Wang L; Xu X; Chen Y; Wang H; Wang G; Zhao J; Chen W
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.